Bristol Myers Squibb and Ehtiwaa Team Up to Support Schizophrenia Patients with 'Small Wins'

Supporting Schizophrenia Patients with 'Small Wins'

In a dedicated effort to assist those living with schizophrenia, Bristol Myers Squibb (BMS) and the Saudi Schizophrenia Association, known as Ehtiwaa, have launched the 'Small Wins' initiative during the 12th edition of Global Patient Week. This collaboration aims to empower patients by encouraging engagement and self-worth through practical activities.

The Importance of Community Initiatives

Schizophrenia is a complex and long-lasting mental health disorder that can affect how individuals interact with others and navigate daily activities. This condition often presents challenges in routine tasks, making it essential to provide supportive tools and community initiatives that foster overall well-being. The 'Small Wins' toolkit represents a practical approach to addressing these challenges and facilitating a more engaged and positive outlook for those affected.

Understanding the 'Small Wins' Toolkit

The 'Small Wins' toolkit is designed not only to motivate but to encourage individuals to celebrate everyday achievements, regardless of their size. It comprises personalized activity cards that promote simple, enjoyable tasks such as:
- Listening to a favorite song
- Spending a few minutes outdoors
- Tidying a small space

Each kit also features a 'Small Wins Jar' where patients can document their daily joys with supportive notes from BMS volunteers, further reinforcing positive self-recognition and engagement in everyday activities. This unique initiative aligns with active psychosocial support and aims to enhance the quality of life for individuals living with schizophrenia.

Employee Involvement in Riyadh

Part of the success of this initiative stems from the enthusiastic involvement of BMS employees. In Riyadh, team members came together to physically assemble over 70 kits. This hands-on activity established a personal connection to the patients they aim to serve, underscoring BMS's commitment to placing patients first. Mayada Al Ahmad, General Manager of BMS KSA, emphasized that the initiative serves as a pathway for employees to engage more deeply with the communities they benefit.

Quotes from Key Figures

Mayada Al Ahmad expressed: "For 12 years, Global Patient Week has allowed our team to build closer connections with patients. We believe that support extends beyond medication, embodying listening, understanding, and active contributions that can significantly enhance lives."

Dr. Manal Sawan of Ehtiwaa shared the importance of this initiative, stating: "The 'Small Wins' initiative is pivotal as it nurtures everyday self-Appreciation—transforming minor achievements into significant improvements in confidence and routine. Our partnership with BMS exemplifies successful collaboration between non-profit and private sectors, enhancing the quality of life for those affected."

A Commitment to Patient Care

Global Patient Week serves as a crucial platform for BMS, reinforcing its dedication to understanding patient experiences by partnering with patient advocacy groups and community organizations. Through this initiative, BMS aims to deepen its commitment to enhancing the lives of individuals facing serious health challenges and showing solidarity with patients globally.

About Bristol Myers Squibb

Bristol Myers Squibb stands as a global biopharmaceutical leader dedicated to discovering and delivering innovative treatments for serious diseases. Focused on oncology, hematology, cardiovascular disease, immunology, and neuroscience, BMS is committed to changing the landscape of healthcare for the better.

About Ehtiwaa

Founded in 2010, the Saudi Schizophrenia Association is a pioneering organization in the Arab world devoted to supporting individuals living with schizophrenia, advancing knowledge, and fostering community integration. Ehtiwaa focuses on enhancing psychosocial support and combating societal stigma surrounding mental health issues.

For more information, visit Bristol Myers Squibb and Ehtiwaa.